Surprisingly, nearly all the pivotal players in this pathway, including PLK1, CDC20, CDC25C, CYCLIN B2 and MLKP1, were downregulated in GPP patients upon acitretin treatment, suggesting a cell cycle-repressing effect of the drug. This evidence concerns the gene CDC20 and psoriasis 14, pustular.